Individuals Coming Off Anti-Obesity Jabs Regain Weight Far More Rapidly Compared to Dieters

A recent study indicates that individuals who come off new weight-loss injections like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt conventional diet and exercise plans.

Published data in a major health publication shows that while overweight individuals can lose a large proportion of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month after stopping.

"Individuals purchasing such medications must be informed of the potential of fast rebound weight gain when the treatment concludes," cautioned expert Dr. Susan Jebb.

This pace of recovery suggests a reversion to starting weight within about one and a half years.

Analyzing Therapies

The analysis, which examined dozens of trials involving over 9,000 of participants, contrasted the effects of the injectable medications with conventional dieting.

The team note that people who lose weight through diet and exercise generally experience a slower weight regain—perhaps 100 grams monthly—after stopping.

Explaining the Fast Regain

Experts believe the way of the jabs explains the amplified weight return.

The injections mimic a natural hormone called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of GLP-1 levels far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this GLP-1 'fix' means appetite is uncontrolled, making excessive eating much more probable."

A Chronic Disease?

Medical guidelines advise the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Professionals say that, considering the likelihood of relapse, the treatment should be considered long-term.

This opinion is echoed by drug manufacturers, who state that the results "underscore the long-term character of obesity," similar to managing diseases like hypertension.

User Accounts

Users who have discontinued the jabs report a sudden return of cravings.

"I experienced a trigger activating and I was suddenly starving," recalled a patient.

This difficulty is exacerbated if users have not adopted lasting dietary or behavioural modifications during treatment.

Significant Use

Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with interest being substantial.

• Adoption is more common among females compared to males.
• The 40s and 50s age group shows the greatest level of interest.
• Many access the medications through private healthcare rather than public health services.

In conclusion, clinicians emphasize that while the jabs are potent tools for weight loss, they are not a standalone cure and long-term success relies on ongoing lifestyle management.